🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Such an honour to receive the young investigator award from my favourite conference. Especially when shared with these amazing researchers! #HAI2025

📢 Dr. Gemma Salvadó (Gemma Salvadó) is the new Group Leader of the #Neuroimaging Research Group at the #BBRC 🙌 Gemma has focused her research on the preclinical stages of Alzheimer's disease, analysing #biomarkers obtained from neuroimaging techniques and biological fluids.

Thrilled to be back home at Barcelonaβeta Brain Research Center as the Lead of the Neuroimaging Group! 🎉 Even better, we have a PhD position open to work with PET & MRI imaging in early stages of #Alzheimer’s. If you know someone passionate about neuroimaging, please share👇 barcelonabeta.org/es/centro-inve…

Excited to share our latest study!🧠Our whole-genome sequencing research on individuals with amyloid PET nominates 26 new candidate genes for amyloidosis and the pivotal role of lipid metabolism.🚀 academic.oup.com/hmg/advance-ar… 4444fpa WashU Medicine Knight ADRC WashU Medicine Neurology

A man who seemed genetically destined to develop Alzheimer’s disease while still young has reached his mid-70s without any cognitive decline ― in only the third recorded case of such resistance to the disease go.nature.com/41cmwvz

Do you use CSF Ab42 or Ab42/40 as a biomarker for “Ab pathology” in Alzheimer's disease? Then I think this paper might be of interest to you. nature.com/articles/s4358…

Next-gen Alzheimer’s drugs extend independent living by months | WashU Medicine medicine.washu.edu/news/next-gen-…

Medical comorbidities could contribute to discordance between plasma biomarkers and Aβ and tau PET findings jamanetwork.com/journals/jaman…

Our paper on TotalSegmentator for MRI images was published in Radiology. paper: pubs.rsna.org/doi/10.1148/ra… code: github.com/wasserth/Total… dataset: zenodo.org/records/147107… online tool: totalsegmentator.com

Excited to see this review of tau and TDP-43 come out, great to work with Laura Wisee, Renaud LaJoie and Bill Jagust 🤩🎉 alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…

Human glymphatic function is severely impaired by SAH, particularly shortly after the event. Glymphatic failure is associated with redistribution of CSF from subarachnoid spaces toward ventricles.

Excited to share our new work in Molecular Neurodegeneration, showing that α-synuclein co-pathology is common in Alzheimer’s and accelerates amyloid-related tau accumulation, supporting its role as a tau co-aggregation factor. doi.org/10.1186/s13024…

In an open-label extension of the phase 2/3 randomised, placebo-controlled platform DIAN-TU trial, Randall Bateman and colleagues assess the safety and efficacy of long-term treatment with high doses of gantenerumab in participants with dominantly inherited Alzheimer's disease.

Meningeal lymphatics-microglia axis regulates synaptic physiology: Cell Press cell.com/cell/fulltext/…

Fantastic presentation by our amazing team member Pati, brilliantly showcasing epidemiological and genetic risk factors of regional white matter hyperintensities using strong statistical methods for profile selection! #ADPD2025 AD/PD - Advances in Science & Therapy Barcelonaβeta Brain Research Center #NBGteam 🧠🧬

Please re-Tweet to raise awareness: When people with #dementia forget, we can help them remember. (image: Tony Husband Cartoon Archive) #Alzheimers #kindness

Alzheimer Europe is delighted to hear that the European Commission has today authorised #lecanemab for treatment of early Alzheimer’s disease (under strict conditions). Find out more: alzheimer-europe.org/news/european-…

Lecanemab has been approved in Europe—the first disease-modifying treatment for #Alzheimer . Now, from public health centers, we must ensure equitable access, minimize risks, and offer the best care. 🧠🏥💚 Barcelonaβeta Brain Research Center Fundación Pasqual Maragall Hospital del Mar ec.europa.eu/newsroom/sante…

🚨Calling all neuroimagers! Help Emma Coomans shape the opening plenary at #AIC2025 (Toronto, July 26th) "Accomplishments of the Past Year" and share the most impactful neuroimaging research from the past year via this brief survey (~5min) by May 30th. act.alz.org/site/R?i=eOejF…

💡 Researchers at CNIC discover a metabolite of the gut #microbiota that could revolutionize the diagnosis and treatment of #atherosclerosis. 🫀 🔝 Why is it important? Detecting this marker in blood is simpler and more accessible than advanced imaging tests, which are